Clinical trial
Research Study Evaluating Cinacalcet for Patients With End Stage Renal Disease…
NCT00113945 · Amgen, Industry · Completed
Key facts
| NCT number | NCT00113945 |
|---|---|
| Title | Research Study Evaluating Cinacalcet for Patients With End Stage Renal Disease (ESRD) |
| Official title | TARGET: Treatment Strategies to Achieve Recommended K/DOQI Goals in ESRD Patients on CinacalceT |
| Lead sponsor | Amgen, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | End Stage Renal Disease |
| Intervention type | Drug |
| Interventions | Cinacalcet |
| Enrollment | 360 |
| Start date | Jul 1, 2003 |
| First posted | Jun 13, 2005 |
| Last update posted | May 13, 2013 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: